This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

HARRIS ISBELL, M.D.; ABRAHAM WIKLER, M.D.; NATHAN B. EDDY, M.D.; JOHN L. WILSON, M.D.; CLIFFORD F. MORAN, M.D.

J Am Med Assoc. 1947;135(14):888-894.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Because the pharmacologic properties of 6-dimethylamino-4-4-diphenyl-heptanone-3 ( methadon)¹ resemble those of morphine and because methadon has been shown to be an effective analgesic substance in animals and in man,² studies of the development of tolerance to certain actions of the drug and of its liability to cause addiction have been carried out by the United States Public Health Service. Since the drug may soon come into clinical use the purpose of the present report is to summarize briefly the data collected to date and to present an opinion of the liability of the drug to cause addiction. More detailed reports are to be published later.

I. ANIMAL EXPERIMENTS

(a) Tolerance.—

Thermal stimulation being used,³ partial tolerance developed to the analgesic action in mice after administration of 5 mg. per kilogram subcutaneously once daily for twenty-nine days. In that period the degree of analgesic response was reduced nearly 50 . . . [Full Text PDF of this Article]

Author Affiliations
Lexington, Ky.; Washington, D. C.; Baltimore

From the Research Department, United States Public Health Service Hospital, Lexington, Ky.; the Division of Physiology, National Institute of Health, Bethesda, Md., and the Tumor Clinic, United States Marine Hospital, Baltimore, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?